Scripps Tumorgraft Study
NCT01726699 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 11
Last updated 2015-04-03
Summary
Study the genetic traits of cancerous tissues and to help improve cancer treatment by developing tumor models for studying new cancer drugs.
Conditions
- Solid Tumor Malignancy or Hematologic Malignancy
Sponsors & Collaborators
-
Scripps Translational Science Institute
lead OTHER
Principal Investigators
-
Laura Goetz, MD · Director, Applied Genetic Epidemiology
Eligibility
- Min Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-11-30
- Primary Completion
- 2014-07-31
- Completion
- 2014-07-31
Countries
- United States
Study Locations
More Related Trials
-
Biomarker Monitoring in TP53 Mutation Carriers
NCT02289326 ·Status: COMPLETED
-
Studying Biomarkers in Tumor Tissue and Blood Samples From Patients With Small Cell Lung Cancer Registered on CALGB-140202
NCT01503619 ·Status: COMPLETED
-
Molecular Profiling Protocol (SCRI-CA-001)
NCT00530192 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Studying Biomarkers in Samples From Younger Patients With Malignant Germ Cell Tumor Progression
NCT01433224 ·Status: COMPLETED
-
An Ancillary Pilot Trial Using Whole Genome Sequencing In Patients With Advance Refractory Cancer
NCT01443390 ·Status: COMPLETED
-
Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples
NCT01034033 ·Status: RECRUITING
-
Studying Genes in Tissue Samples From Younger and Adolescent Patients With Soft Tissue Sarcomas
NCT01567046 ·Status: COMPLETED
-
Studying Tumor Tissue Samples and Blood Samples to Learn More About DNA Changes in Patients With Lung Cancer
NCT00899405 ·Status: RECRUITING
-
Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment
NCT05600933 ·Status: ENROLLING_BY_INVITATION
-
Studying Gene Expression in Samples From Patients With Rhabdoid Tumors
NCT01553175 ·Status: COMPLETED
-
Biomarkers in Stored Tumor Samples From Younger Patients With Liver Cancer
NCT00899002 ·Status: WITHDRAWN
-
Analysis of Prostate Cancer Short-Term Cultures Using Molecular Cytogenetic Methods
NCT00022919 ·Status: COMPLETED
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
NCT01441089 ·Status: RECRUITING
-
Studying Biomarkers in Samples From Patients With High-Risk Neuroblastoma
NCT01510600 ·Status: COMPLETED
-
SCRI Tissue Testing Registry
NCT00965861 ·Status: TERMINATED
-
Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma
NCT00579566 ·Status: RECRUITING
-
Comprehensive Genomic Analysis in Tissue and Blood Samples From Young Patients With Lung Cancer
NCT02273336 ·Status: COMPLETED
-
Targeted Genomic Analysis of Blood and Tissue Samples From Patients With Cancer
NCT02688517 ·Status: RECRUITING
-
CIRculating Cell-free nUcLeic Acids in Cancer Therapy Monitoring -01
NCT05871593 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Recurrence Monitoring in NSCLC Using Circulating Tumor DNA
NCT03878537 ·Status: UNKNOWN
-
Study of Specimens From Young Patients With Neuroblastoma
NCT00958659 ·Status: COMPLETED
-
Analysis of Genes Present in Cutaneous T-cell Lymphoma Cells
NCT00020072 ·Status: COMPLETED ·Phase: NA
-
Rare Tumors and Cancer Predisposition in Individuals and Families
NCT05350761 ·Status: RECRUITING
-
Studying Gene Expression in Samples From Younger Patients With Neuroblastoma
NCT01553448 ·Status: COMPLETED
-
Biomarker in Tumor Tissue Samples From Patients With Rhabdomyosarcoma
NCT01365962 ·Status: COMPLETED